Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?

  • Letter to the Editor
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Sharabi Y, Dendi R, Holmes C, Goldstein DS (2003) Baroreflex failure as a late sequela of neck irradiation. Hypertension 42:110–116

    Article  CAS  Google Scholar 

  2. Heusser K, Tank J, Luft FC, Jordan J (2005) Baroreflex failure. Hypertension 45:834–839

    Article  CAS  Google Scholar 

  3. Iodice V, Kimpinski K, Vernino S, Sandroni P, Low PA (2009) Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci 146:22–25

    Article  CAS  Google Scholar 

  4. Gibbons CH, Schmidt P, Biaggioni I et al (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 264:1567–1582

    Article  Google Scholar 

  5. Gibbons CH, Vernino SA, Kaufmann H, Freeman R (2005) l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology 65:1104–1106

    Article  Google Scholar 

Download references

Funding

This project was supported by the National Institute of Health and National Institute of Neurological Disorders and Stroke (NIH/NINDS U54 NS065736).

Author information

Authors and Affiliations

  1. Drexel University College of Medicine, Philadelphia, PA, USA

    Maureen C. Farrell

  2. The University of Illinois at Chicago College of Medicine, Chicago, IL, USA

    Alexander S. Brenner

  3. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, 506 Robinson Research Building, Nashville, TN, 37232-6602, USA

    Cyndya A. Shibao

Authors
  1. Maureen C. Farrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander S. Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cyndya A. Shibao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cyndya A. Shibao.

Ethics declarations

Conflict of interest

M.C.F. and A.S.B. have no conflicts of interest to declare. C.A.S. has received a research grant from the Doris Duke Foundation. C.A.S. received grant support from the Office of Orphan Products Development, Food and Drug Administration, grant #FD-R-04778-01-A3. C.A.S. has received a speaker honorarium from Lundbeck Pharmaceuticals. C.A.S. received consulting honoraria from Lundbeck and Theravance Biopharma. C.A.S is a member of the board for the American Autonomic Society.

Ethical standards

This work was approved by the Institutional Review Board and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farrell, M.C., Brenner, A.S. & Shibao, C.A. Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?. Clin Auton Res 28, 589–591 (2018). https://doi.org/10.1007/s10286-018-0556-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-018-0556-5

Keywords

Search

Navigation